Klingmüller Lab - Systems Biology of Signal Transduction (DKFZ)
@klingmuelab.bsky.social
Official account of Ursula Klingmüller's lab at the German Cancer Research Center in Heidelberg. We are focussing on quantitative biology, mathematical models of signaling pathways, systems medicine, and proteomics.
This account is managed by lab members
This account is managed by lab members
Pinned
We are very happy to see that so many scientists moved to Bluesky! Let us help to connect the DKFZ community here 💙
go.bsky.app/V64sJYM
go.bsky.app/V64sJYM
Reposted by Klingmüller Lab - Systems Biology of Signal Transduction (DKFZ)
Second Heidelberg Interferons Symposium coming up!! If you are based in HD or Mannheim (@dkfz.bsky.social, @uniheidelberg.bsky.social, @hlsalliance.bsky.social, @embl.org,...) and interested in any facet of these incredible #cytokines, join us on
🗓️ July 10/11
🏫 Marsilius Kolleg
✍🏻 bit.ly/IFN2025
🗓️ July 10/11
🏫 Marsilius Kolleg
✍🏻 bit.ly/IFN2025
May 9, 2025 at 9:10 AM
Second Heidelberg Interferons Symposium coming up!! If you are based in HD or Mannheim (@dkfz.bsky.social, @uniheidelberg.bsky.social, @hlsalliance.bsky.social, @embl.org,...) and interested in any facet of these incredible #cytokines, join us on
🗓️ July 10/11
🏫 Marsilius Kolleg
✍🏻 bit.ly/IFN2025
🗓️ July 10/11
🏫 Marsilius Kolleg
✍🏻 bit.ly/IFN2025
Our lab is currently at the e:Med Meeting 2024
on Systems Medicine 💊 in Hamburg! @sebdl.bsky.social and Dr. Marcel Schilling already gave talks on their approaches to improve patient care for NAFLD/liver cancer and EPO treatment in chronic kidney disease 🙌🏻
on Systems Medicine 💊 in Hamburg! @sebdl.bsky.social and Dr. Marcel Schilling already gave talks on their approaches to improve patient care for NAFLD/liver cancer and EPO treatment in chronic kidney disease 🙌🏻
November 23, 2024 at 9:30 AM
Our lab is currently at the e:Med Meeting 2024
on Systems Medicine 💊 in Hamburg! @sebdl.bsky.social and Dr. Marcel Schilling already gave talks on their approaches to improve patient care for NAFLD/liver cancer and EPO treatment in chronic kidney disease 🙌🏻
on Systems Medicine 💊 in Hamburg! @sebdl.bsky.social and Dr. Marcel Schilling already gave talks on their approaches to improve patient care for NAFLD/liver cancer and EPO treatment in chronic kidney disease 🙌🏻
Reposted by Klingmüller Lab - Systems Biology of Signal Transduction (DKFZ)
It was a pleasure to share our novel findings regarding liver disease progression in the eMED conference. www.linkedin.com/posts/sebast...
Sebastian Burbano de Lara on LinkedIn: It was an honor to present our findings at the eMED conference. Thanks to…
It was an honor to present our findings at the eMED conference. Thanks to Bundesministerium für Bildung und Forschung for funding our efforts to advance the…
www.linkedin.com
November 22, 2024 at 1:19 PM
It was a pleasure to share our novel findings regarding liver disease progression in the eMED conference. www.linkedin.com/posts/sebast...
Reposted by Klingmüller Lab - Systems Biology of Signal Transduction (DKFZ)
Hello DKFZ people! I hope this list will grow and help all new bluesky members from our institute to find each other here ☺️
go.bsky.app/V64sJYM
go.bsky.app/V64sJYM
November 19, 2024 at 10:20 AM
Hello DKFZ people! I hope this list will grow and help all new bluesky members from our institute to find each other here ☺️
go.bsky.app/V64sJYM
go.bsky.app/V64sJYM
We are very happy to see that so many scientists moved to Bluesky! Let us help to connect the DKFZ community here 💙
go.bsky.app/V64sJYM
go.bsky.app/V64sJYM
November 19, 2024 at 10:24 AM
We are very happy to see that so many scientists moved to Bluesky! Let us help to connect the DKFZ community here 💙
go.bsky.app/V64sJYM
go.bsky.app/V64sJYM